Table 1 |
||
|
Summary of peptides identified with a PeptideProphet P score ≥0.9 |
||
| Peptide |
Counts |
Percentage |
|
|
||
| Total assignment above threshold |
800,507 |
|
| Total correct assignment |
791,069 |
|
| Total incorrect assignment |
9,438 |
|
| Spectrum assignment false discovery rate |
0.012 |
|
| Total distinct peptides |
13,779 |
100.00 |
| Distinct peptides mapped to human genome |
13,461 |
97.69 |
| Possible proteins implicated in mapping |
10,674 |
|
| Simple reduced proteins |
4,084 |
|
| Simple reduced genes |
3,580 |
|
| Unambiguously mapped proteins |
1,590 |
|
| Total distinct peptides, presented in ≥2 samples |
9,170 |
66.55 |
| Total singleton distinct peptides |
4,609 |
33.45 |
| Cys-containing distinct peptides |
3,709 |
26.92 |
| Trp-containing distinct peptides |
2,067 |
15.00 |
| Lys-containing distinct peptides |
8,392 |
60.90 |
| Total distinct peptides from colon cancer versus normal |
5,958 |
|
| Total distinct peptides from breast cancer versus normal |
8,874 |
|
| Total distinct peptides from pancreatic cancer versus normal |
7,753 |
|
| Total distinct peptides from ovarian cancer versus normal |
5,368 |
|
| Total distinct peptides in all four reference sets |
2,897 |
21.02 |
| Total distinct peptides in three reference sets |
1,534 |
11.13 |
| Total distinct peptides in two reference sets |
2,415 |
17.53 |
|
|
||
|
Zhang et al. Genome Biology 2008 9:R93 doi:10.1186/gb-2008-9-6-r93 |
||
